Abionyx Pharma
609
Company Profile
Business description
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.
Contact
33-43 Avenue Georges Pompidou-Bat D2
Balma 31130
FRAT: +33 562249706
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2024
Employees
61
Stocks News & Analysis
stocks
3 shares with high dividend yields from our Global Best Ideas list
These three picks trade at a significant discount to our fair value and all offer dividend yields above 4.5%.
video
Our view of mining shares
Morningstar Equity Analyst Jon Mills walks through our view of the sector and opportunities for investors.
stocks
Undervalued ASX share with robust cash flow
This energy share features robust production and cash flow which bodes well for shareholder returns.
Morningstar Investment Ideas
Stocks
ETFs
- Australian ETFs
- Active Australian Equity ETFs
- Passive Australian Equity ETFs
- Emerging Market Equity ETFs
- Sustainable ETFs
- Active Global Equity ETFs
- Passive Global Equity ETFs
- Active Australian Fixed Interest ETFs
- Passive Australian Fixed Interest ETFs
- Active Australian Listed Property ETFs
- Passive Australian Listed Property ETFs
- Active Global Fixed Interest ETFs
- Passive Global Fixed Interest ETFs
- Active Global Infrastructure ETFs
- Passive Global Infrastructure ETFs
- Active Global Property ETFs
- Passive Global Property ETFs
Funds
- Active Australian Equity Funds
- Passive Australian Equity Funds
- Active Global Equity Funds
- Passive Global Equity Funds
- Sustainable Funds
- Emerging Market Equity Funds
- Passive Australian Listed Property Funds
- Active Australian Listed Property Funds
- Passive Global Infrastructure Funds
- Active Global Infrastructure Funds
- Active Global Property Funds
- Passive Global Property Funds
- Active Australian Fixed Interest Funds
- Passive Australian Fixed Interest Funds
- Active Global Fixed Interest Funds
- Passive Global Fixed Interest Funds
Markets
Index
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| All Ordinaries | 8,208.60 | 42.20 | 0.52% |
| CAC 40 | 7,622.02 | 87.50 | 1.16% |
| DAX 40 | 18,407.07 | 235.14 | 1.29% |
| Dow JONES (US) | 40,415.44 | 127.91 | 0.32% |
| FTSE 100 | 8,196.28 | 2.50 | -0.03% |
| HKSE | 17,487.34 | 148.54 | -0.84% |
| NASDAQ | 18,007.57 | 280.63 | 1.58% |
| Nikkei 225 | 39,594.39 | 4.61 | -0.01% |
| NZX 50 Index | 12,425.58 | 115.67 | 0.94% |
| S&P 500 | 5,564.41 | 59.41 | 1.08% |
| S&P/ASX 200 | 7,971.10 | 39.40 | 0.50% |
| SSE Composite Index | 2,916.64 | 47.58 | -1.60% |
Market Movers
Name
|
Last price
|
Change
|
% Change
|
|---|---|---|---|
| Alumina Ltd AWC | 1.45 | 0.03 | -1.69% |
| Sayona Mining Ltd SYA | 0.03 | 0.00 | 0.00% |
| Droneshield Ltd DRO | 1.42 | 0.13 | -8.39% |
| Zip Co Ltd ZIP | 1.80 | 0.11 | 6.19% |
| Core Lithium Ltd CXO | 0.10 | 0.00 | -2.00% |
| South32 Ltd S32 | 2.98 | 0.01 | -0.33% |
| Spartan Resources Ltd SPR | 1.23 | 0.24 | 23.62% |
| Pilbara Minerals Ltd PLS | 2.89 | 0.00 | 0.00% |
| Imugene Ltd IMU | 0.06 | 0.00 | 7.14% |
| Mesoblast Ltd MSB | 1.31 | 0.15 | 12.99% |